Stock Analysis
Rocket Lab Corporation (RKLB)
NASDAQ: RKLB · Aerospace & Defence
Updated
Rated Watchlist, with a fair value of $55 against a last close of $59.18 (-7.1% implied upside). Rocket Lab moved Neutron's first launch from the fourth quarter of 2026 into 2027, cutting the base case to $55 from $70; at $59.18 the shares sit above it, so Watchlist holds and the watch price falls to $45.
- Verdict
- Watchlist
- Fair Value
- $55
- Investment Score
- 58/100prev 63.2
Technical read (chart only): Confirms as of A downtrend below a falling 50-day average of $70.12 and the 200-day at $81.43; watch whether the $58.60 closing low of 29 July gives way, and look for a reclaim of the 50-day followed by a higher low.The Watchlist verdict comes from the fundamentals alone. The technical read looks only at the price chart. It does not change the verdict or the score and only guides entry timing.
Investment Scorecard
Composite score 58/100 (previous 63.2). Every factor is scored out of 10, ten always being the best outcome, including for risk.
| Factor | Score | Weight | Change | Basis |
|---|---|---|---|---|
| Business Quality | 7/10 | 16% | unchanged | Leading small launcher plus a broad Space Systems platform; 41.5% non-GAAP gross margin in Q2. |
| Financial Strength | 7/10 | 16% | unchanged | About $2.39bn cash and securities at June with little debt; Iridium cash need funded; still burning cash. |
| Competitive Advantage | 6/10 | 16% | -1 vs last report | Electron leads small launch, but medium lift is unproven and Neutron's lead over new entrants narrows with the delay. |
| Management | 6/10 | 10% | -1 vs last report | Strong on the business and the Iridium funding; Neutron dates missed again. |
| Growth Potential | 7/10 | 16% | -1 vs last report | Backlog up 137% to $2.36bn, but Neutron revenue pushed later. |
| Valuation | 3/10 | 16% | unchanged | About 28x base-case 2027 revenue; price above the $55 base case. |
| Risk (10 = lowest risk) | 4/10 | 10% | -1 vs last report | Neutron binary open longer; Iridium loan guarantee and FCC approval pending. |
Recent Developments
| Date | Development | Impact |
|---|---|---|
| Neutron first launch moved to 2027 Form 8-K and release after the 14 October close: first launch now expected in 2027, from a Q4 2026 target, as development continues and process improvements are incorporated. No date, cost or guidance change stated. Earlier: stage 1 tank burst in a 21 January pressure test; August plan was pad delivery in Q4 2026 with a narrowing launch window. Reading: Our sizing: about $82m (6%) less 2027 revenue than on the old timetable and about $7.60 a share less value, mostly through a lower multiple; base case $55 against $62 without the delay. Moves four factor scores and the watch price, not the verdict. | High | |
| Third-quarter 2026 results Expected 9 November; not yet confirmed on the company's events page. Q3 guide: revenue $250-265m, adjusted EBITDA loss $17-23m. Reading: First chance for management to date Neutron within 2027 and size the cost of the delay. | Medium | |
| Synspective 20-launch Electron contract 20 Electron launches flown 2028-2031; value not disclosed. Reading: Our estimate about $40m a year from 2028; long-dated Electron visibility, unaffected by Neutron. | Medium | |
| Iridium acquisition funded and approved by Iridium holders $27 cash plus collared Rocket Lab stock per Iridium share (collar $67.50-$112.50); about $8.0bn enterprise value; close expected mid-2027 subject to FCC approval; Rocket Lab to guarantee Iridium's $1.775bn term loans. Reading: Treated as roughly value-neutral per share; FCC timing is the remaining risk. The share price now sits below the collar's lower bound. | Medium |
Key Risks
| Risk | Probability | Severity | Comment |
|---|---|---|---|
| Valuation compression | High | High | About 28x base-case 2027 revenue at the $59.18 close. |
| Integration of Iridium | Medium | High | Iridium's revenue is close to Rocket Lab's own. |
| Iridium FCC timing or conditions | Low-Medium | High | Closing expected mid-2027; guarantee of $1.775bn term loans. |
| Share price volatility | High | Medium | Average daily range about 6.6% of price. |
| Rising long-term yields | Medium | Medium | 10-year near 5.2%, 30-year near 5.6%; long-duration growth shares most exposed. |
| Government programme concentration | Medium | Medium | Defence awards depend on appropriations. |
| Neutron slips further or its first flight fails | Medium | Very High | Second delay this year; first flights of new rockets often fail. |
Scenario Analysis
| Case | Probability | Fair Value | Outlook |
|---|---|---|---|
| Bull | 20% | $72 | Neutron flies in the first half of 2027 with two revenue flights, Space Systems beats plan and Iridium closes on time; 2027 revenue about $1.38bn at 32x. |
| Base | 50% | $55 | First Neutron flight around mid-2027 with little 2027 revenue, backlog converts near guidance, Iridium closes mid-2027; 2027 revenue about $1.27bn at 26x. |
| Bear | 30% | $33 | Neutron slips into 2028 or its first flight fails, awards slow and the multiple resets; 2027 revenue about $1.20bn at 16x. |
The Case
Outside Neutron, Rocket Lab is executing: record revenue, a $2.36bn backlog, a 20-launch Electron contract and the Iridium deal funded. But Neutron, the programme the premium multiple rests on, has moved into 2027 with no date, cutting the base case to $55, below the $59.18 close. The biggest concern is Neutron's schedule and first-flight risk; near $45, or on a dated 2027 window followed by a static fire, the answer changes.
Archived Reports
Beating The Bull keeps every past version of this report on file. Verdicts and numbers reflect what was known when each one was published.
Informational use only. Not financial advice.